Iastrebner, M., Castro, J., García Espina, E., Lettieri, C., Payaslian, S., Cuesta, M. C., . . . Caruso, V. (2021). Ruxolitinib in severe COVID-19: Results of a multicenter, prospective, single arm, open-label clinical study to investigate the efficacy and safety of ruxolitinib in patients with COVID-19 and severe acute respiratory syndrome. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología.
Cita Chicago Style (17a ed.)Iastrebner, Marcelo, et al. Ruxolitinib in Severe COVID-19: Results of a Multicenter, Prospective, Single Arm, Open-label Clinical Study to Investigate the Efficacy and Safety of Ruxolitinib in Patients with COVID-19 and Severe Acute Respiratory Syndrome. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología, 2021.
Cita MLA (8a ed.)Iastrebner, Marcelo, et al. Ruxolitinib in Severe COVID-19: Results of a Multicenter, Prospective, Single Arm, Open-label Clinical Study to Investigate the Efficacy and Safety of Ruxolitinib in Patients with COVID-19 and Severe Acute Respiratory Syndrome. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología, 2021.